Novi Nordisk now highlights the advances in diabetic treatment through its Insulin Symposium organised during the 73rd Annual Conference of the Association of Physicians of India (APICON) 2018.
The symposium being held in Bengaluru from February 22 to 24, 2018, comes on the back of Novo Nordisk’s renewed commitment to educate the physician community on advancements in diabetes treatment. The need for reaching out stems from a strong engagement between the patients and physicians. Usually, physicians are one of the first to diagnose diabetes and can play a key role in improving patients’ diabetes related literacy, said the company.
Anil Kumble, Changing Diabetes brand ambassador and former captain and coach of the Indian cricket team inaugurated the Insulin Symposium.
According to IDF Atlas 8th edition, 72.9 million people have diabetes in India and over 58% people have undiagnosed diabetes.
In his opening address at the symposium, Kumble said: “Diabetes in India is on the rise. I am glad that I have the opportunity to be a part of the Changing Diabetes mission spearheaded by Novo Nordisk India. To manage diabetes, it is essential that one gets timely diagnosis and early initiation of treatment combined with simple lifestyle modifications. Physicians need to motivate people to recognise the need to know their risk at the earliest for managing diabetes better.”
The workshop conducted by leading city-based diabetologists focused on increasing the participating physicians’ knowledge about the progression of diabetes, the physiological effects of insulin, and tools for successfully initiating insulin in patients with type 2 diabetes. Approximately 300 doctors benefitted from this.
“We are committed towards creating awareness about diabetes and ensuring people with diabetes are provided with best-in-class quality medication. APICON is the right platform for healthcare professionals to congregate and converse on the latest in diabetes care treatment and best practices. We are happy to support API Karnataka Chapter in their endeavour to create a platform to ideate, debate and share scientific updates on diabetes,” stated Melvin D’souza, Managing Director, Novo Nordisk India.
According to Dr. M. Maiya, Chairman, Organizing Committee APICON 2018 the association aims to promote collaboration, enabling knowledge sharing, advancing treatment practices and skills, and supporting academic endeavour in the field of medicine in India, by conducting its annual national conferences in various cities of India.